Follow
Michael Linden MD PhD
Title
Cited by
Cited by
Year
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
SA Buckley, BL Wood, M Othus, CS Hourigan, C Ustun, MA Linden, ...
haematologica 102 (5), 865, 2017
2592017
Novel targeted deregulation of c-Myc cooperates with Bcl-XL to cause plasma cell neoplasms in mice
WC Cheung, JS Kim, M Linden, L Peng, B Van Ness, RD Polakiewicz, ...
The Journal of clinical investigation 113 (12), 1763-1773, 2004
1442004
The comparative diagnostic features of canine and human lymphoma
DM Seelig, AC Avery, EJ Ehrhart, MA Linden
Veterinary sciences 3 (2), 11, 2016
1292016
Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells
PA Croonquist, MA Linden, F Zhao, BG Van Ness
Blood 102 (7), 2581-2592, 2003
982003
Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model
HAF Stessman, LB Baughn, A Sarver, T Xia, R Deshpande, A Mansoor, ...
Molecular cancer therapeutics 12 (6), 1140-1150, 2013
902013
Myeloablative, but not reduced-intensity, conditioning overcomes the negative effect of flow-cytometric evidence of leukemia in acute myeloid leukemia
C Ustun, EL Courville, T DeFor, M Dolan, N Randall, S Yohe, N Bejanyan, ...
Biology of Blood and Marrow Transplantation 22 (4), 669-675, 2016
682016
Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies
M Linden, N Kirchhof, C Carlson, B Van Ness
Blood 103 (7), 2779-2786, 2004
582004
Single-cell gene expression analyses reveal distinct self-renewing and proliferating subsets in the leukemia stem cell compartment in acute myeloid leukemia
K Sachs, AL Sarver, KE Noble-Orcutt, RS LaRue, ML Antony, D Chang, ...
Cancer research 80 (3), 458-470, 2020
532020
Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib
HAF Stessman, A Mansoor, F Zhan, S Janz, MA Linden, LB Baughn, ...
Leukemia 27 (10), 2075-2077, 2013
532013
Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice
JD Riordan, CR Feddersen, BR Tschida, PJ Beckmann, VW Keng, ...
Hepatology 67 (3), 924-939, 2018
412018
Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors
BR Tschida, NA Temiz, TP Kuka, LA Lee, JD Riordan, CA Tierrablanca, ...
Cancer research 77 (23), 6576-6588, 2017
392017
Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas
C Xie, H Lu, A Nomura, EA Hanse, CL Forster, JB Parker, MA Linden, ...
Molecular cancer 14, 1-11, 2015
352015
Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML
C Ustun, AC Wiseman, TE Defor, S Yohe, MA Linden, B Oran, M Burke, ...
Bone marrow transplantation 48 (11), 1415-1420, 2013
352013
Assessment of circulating tumor cells as a predictive biomarker of histology in women with suspected ovarian cancer
E Lou, RI Vogel, D Teoh, S Hoostal, A Grad, M Gerber, M Monu, ...
Laboratory medicine 49 (2), 134-139, 2018
342018
Marked variability in reported minimal residual disease lower level of detection of 4 hematolymphoid neoplasms: a survey of participants in the College of American Pathologists†…
M Keeney, JG Halley, DD Rhoads, MQ Ansari, SJ Kussick, WJ Karlon, ...
Archives of pathology & laboratory medicine 139 (10), 1276-1280, 2015
312015
ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis
JC To, AP Chiu, BR Tschida, LH Lo, CH Chiu, XX Li, TP Kuka, MA Linden, ...
JHEP Reports 3 (2), 100223, 2021
292021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv (16) vs t (8; 21)
SY Han, K Mrůzek, J Voutsinas, Q Wu, EA Morgan, H Vestergaard, ...
Blood advances 5 (10), 2481-2489, 2021
282021
Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity
H Lu, S Bhoopatiraju, H Wang, NP Schmitz, X Wang, MJ Freeman, ...
Oncotarget 7 (46), 76047, 2016
272016
Variability in the laboratory measurement of cytokines: a longitudinal summary of a College of American Pathologists proficiency testing survey
V Knight, T Long, QH Meng, MA Linden, DD Rhoads
Archives of pathology & laboratory medicine 144 (10), 1230-1233, 2020
262020
Hematopoietic and lymphoid tissues
JM Ward, S Cherian, MA Linden
Comparative Anatomy and Histology, 365-401, 2018
252018
The system can't perform the operation now. Try again later.
Articles 1–20